Ulrich, C.; Wilke, A.; Schleicher, N.; Girndt, M.; Fiedler, R.
Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ß but IL-6 and IL-10 Activation in Haemodialysis Patients. Toxins 2020, 12, 159.
https://doi.org/10.3390/toxins12030159
AMA Style
Ulrich C, Wilke A, Schleicher N, Girndt M, Fiedler R.
Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ß but IL-6 and IL-10 Activation in Haemodialysis Patients. Toxins. 2020; 12(3):159.
https://doi.org/10.3390/toxins12030159
Chicago/Turabian Style
Ulrich, Christof, Annegret Wilke, Nadja Schleicher, Matthias Girndt, and Roman Fiedler.
2020. "Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ß but IL-6 and IL-10 Activation in Haemodialysis Patients" Toxins 12, no. 3: 159.
https://doi.org/10.3390/toxins12030159
APA Style
Ulrich, C., Wilke, A., Schleicher, N., Girndt, M., & Fiedler, R.
(2020). Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ß but IL-6 and IL-10 Activation in Haemodialysis Patients. Toxins, 12(3), 159.
https://doi.org/10.3390/toxins12030159